Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

saxagliptin 5 MG Oral Tablet [Onglyza]

Known as: Onglyza (as saxagliptin hydrochloride 5.58 MG) 5 MG Oral Tablet, onglyza 5 MG Oral Tablet, saxagliptin hydrochloride 5 mg ORAL TABLET, FILM COATED [ONGLYZA] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Saxagliptin (Onglyza®) is a highly potent, reversible, competitive dipeptidyl peptidase-4 inhibitor indicated for the treatment… Expand
  • table 1
  • table 2
  • table 3
2014
2014
Oral saxagliptin (Onglyza®), a potent, selective dipeptidyl pepitase-4 inhibitor, is a useful option to improve glycaemic control… Expand
2012
2012
AIM The objective of this study was to investigate the cost-effectiveness of saxagliptin (Onglyza(®)), a DPP-4 inhibitor, plus… Expand
Review
2012
Review
2012
  • L. Yang
  • Drugs
  • 2012
  • Corpus ID: 195687875
Saxagliptin (Onglyza™) is a dipeptidyl peptidase 4 inhibitor widely approved for the treatment of type 2 diabetes mellitus. In… Expand
2012
2012
A liquid chromatography and tandem mass spectrometry (LC-MS/MS) method was developed and validated to simultaneously determine… Expand
2012
2012
Saxagliptin (Onglyza™) is a dipeptidyl peptidase‐4 (DPP4) inhibitor for treating type 2 diabetes mellitus. This open‐label… Expand
2010
2010
  • A. Chacra
  • Diabetes, metabolic syndrome and obesity…
  • 2010
  • Corpus ID: 31343898
Saxagliptin (Onglyza™) is a potent, selective, once-daily dipeptidyl peptidase-4 (DPP-4) inhibitor indicated for improving… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
2010
2010
• L'enzyme DPP-4 degrade physiologiquement les incretines GLP-1 et GIP. • La saxagliptine (Onglyza ® ) est un inhibiteur oral de… Expand